SIOPEN Publications
Recent Evidence-Based Clinical Guide for the Use of Dinutuximab Beta in Pediatric Patients with Neuroblastoma
Balaguer J, García Hidalgo L, Hladun R, Márquez Vega C, Pérez Alonso V.
Optimising urinary catecholamine metabolite diagnostics for neuroblastoma
Yvette A H Matser, Iedan R N Verly, Maria van der Ham, Monique G M de Sain-van der Velden, Nanda M Verhoeven-Duif, Shifra Ash, Giuliana Cangemi, Sebastiano Barco, Maja Beck Popovic, André B P van Kuilenburg, Godelieve A M Tytgat ; SIOPEN Catecholamine Working Group
Pediatr Blood Cancer. 2023 Jun;70(6):e30289. doi: 10.1002/pbc.30289. Epub 2023 Apr 3
Radiotherapy quality assurance in paediatric clinical trials: first report from six QUARTET-affiliated trials
Sarah M Kelly, Andrada Turcas, Coreen Corning, Simon Bailey, Adela Cañete, Enrico Clementel, Andrea di Cataldo, Karin Dieckmann, Mark N Gaze, Gail Horan, Meriel Jenney, Ruth Ladenstein, Laetitia Padovani, Dominique Valteau-Couane, Tom Boterberg, Henry Mandeville
Radiother Oncol. 2023 May;182:109549. doi: 10.1016/j.radonc.2023.109549. Epub 2023 Feb 23
Overcoming inter-observer planning variability in target volume contouring and dose planning …
for high-risk neuroblastoma - a European multicenter effort of the SIOPEN radiotherapy committee
Danny Jazmati, Lorenzo Brualla, Annemieke S Littooij, Britta Webber, Karin Dieckmann, Geert O Janssens, Thorsten Simon, Mark N Gaze , Julien Merta, Antonio Serrano, Stefan Dietzsch, Paul-Heinz Kramer, Jörg Wulff, Tom Boterberg, Beate Timmermann
Radiother Oncol. 2023 Apr;181:109464. doi: 10.1016/j.radonc.2023.109464. Epub 2023 Jan 11